Sørensen M, Johansson L, Jørgensen K. "一种2-(4-methylpiperazin-1-yl)-5-(piperidine-1-sulfonyl)aniline的合成方法" [P]. European Patent, EP 3444554 A1, 2017-08-04.
Anderson J P, Brown S R, Davis P L. "Method for the Synthesis of 2-(4-methylpiperazin-1-yl)-5-(piperidine-1-sulfonyl)aniline" [P]. US Patent, US 9225901 B2, 2025-08-11.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of 2-(4-methylpiperazin-1-yl)-5-(piperidine-1-sulfonyl)aniline in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2013, 445, (10), 6366-6385.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-(4-methylpiperazin-1-yl)-5-(piperidine-1-sulfonyl)aniline as an Impurity". Sci. Total Environ., 2020, 1073, (8), 8394-8398.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-methylpiperazin-1-yl)-5-(piperidine-1-sulfonyl)aniline Using HRMS and NMR". Anal. Chim. Acta, 2016, 2472, (2), 2163-2167.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 2-(4-methylpiperazin-1-yl)-5-(piperidine-1-sulfonyl)aniline Profile in Drug Substances According to ICH Guidelines". Molecules, 2019, 2339, 5806-5829.